CD127
- 
FoxP3
+ regulatory T cells (Tregs) in peripheral tolerance and immune homeostasis. First, Sakaguchi et al. [1] described the role of CD4 + CD25
+ Tregs in immunologic self-tolerance in the mouse. Second, the transcription factor FoxP3 is required for the development of CD4 + CD25
+ Tregs [2, 3] . Third, mutations in the FoxP3 gene are linked to Treg deficiency and cause autoimmune syndromes in mice and humans [4, 5] . Impairment of Tregs may also contribute to common autoimmune diseases but in humans, the analysis is hampered by the fact that a specific surface marker, which unequivocally defines Tregs, is missing. FoxP3 is localized intracellular and not suitable to select Tregs for functional analysis. Whereas in mice expression of CD25 is restricted to CD4 + CD25 +
+ Tregs, in humans CD25 is also present on recently activated conventional CD4 + T cells [6] , yet FoxP3 expression correlates with the intensity of CD25 surface staining [7] . The suppressive activity was confined to the CD4 + CD25
high T cell population [8] . Only 1 -2 % of CD4 + T cells express constitutively high levels of CD25 while the expression is intermediate (interm) to low on 30 % of CD4 + T cells [6] . However, the purity and recovery of Tregs depends on the gating strategy of CD4 +
CD25
high versus CD4 + CD25 interm T cells. Therefore additional marker such as CD39 [9, 10] or CD127 [11, 12] have been introduced to separate Tregs from conventional activated T cells. CD39 is not only expressed on CD4+CD25 high T cells but also present on CD4 +
interm/low T cells [9] and expression correlate but does not completely overlap with the CD4 + CD25
high T cell population [10] . Expression of CD127 inversely correlates with FoxP3 and up to 93.6 % of the CD4
-/low T cells are FoxP3 positive [12] . This correlation is not absolute because some CD127 [14] . Numerical and / or functional deficiencies of Tregs have been described in a variety of autoimmune diseases [15] [16] [17] [18] [19] [20] [21] [22] . Most studies describe reduced Treg cell numbers in patients compared to healthy individuals but Treg cell numbers were also reported to be normal depending on activity, severity or course of the disease [15] [16] [17] [18] [19] [20] [21] [22] [23] . Functional deficiency of Tregs was described in multiple sclerosis [15] [16] [17] [18] [19] , systemic lupus erythematosus [20] , rheumatoid arthritis [21] , and diabetes type 1 [22, 23] .
Functional analysis is usually performed with highly selected Tregs and autologous CD4 +
-Teffs in the presence of antigen specific or polyclonal T cell activation. Assuming that only numerical but not functional alterations of Tregs occur in autoimmune diseases, highly selected Tregs from healthy individuals as well as patients should display equivalent functional properties in polyclonal activated T cell suppression assays. This is however not the case which indeed implicates functional impairment of Tregs but heterogeneity of Tregs and / or T effector cells (Teffs) is still another option. Kleinewietfeld et al. [24] used CD49d antibodies to obtain negatively selected untouched Tregs for in vitro expansion but low suppressive activity was also seen in the CD49d + T cell control. 
Material and Methods

Antibodies
The following antibodies were used for magnetic activated cell separation (MACS): "CD4 + CD25 + Regulatory T Cell Isolation Kit II, human" (Miltenyi Biotec, Bergisch-Gladbach, Germany). The kit contains a CD4 + T Cell Biotin-Antibody Cocktail (biotin-conjugated monoclonal anti-human antibodies against CD8, CD14, CD15, CD16, CD19, CD36, CD56, CD123, TCRγ/δ and CD235a); anti-Biotin Microbeads and CD25 Microbeads (microbeads conjugated with monoclonal anti-CD25 antibodies). The following anti-human monoclonal antibodies were used for fluorescence activated cell analysis or sorting (FACS): "Human Regulatory T Cell Cocktail" (anti-CD4-FITC, anti-CD25-PE-Cy7, anti-CD127-Alexa Fluor 647), anti-CD49d-PE-Cy5 (both BD Pharmingen), anti-CD45RA-V450 (BD Horizon). Monoclonal antibodies of equivalent isotype were used to control unspecific staining. 
Cell separation
Suppression assay
In vitro suppression assays were carried out in RPMI 1640 culture medium supplemented with 10 % human serum. 5x10 4 Teffs together with 1x10 5 irradiated (30 Gy) autologous PBMCs were stimulated with monoclonal anti-CD3 antibodies (OKT3, 0.5 µg/ml; BD Biosciences, Heidelberg, Germany) in a final volume of 200 µl culture medium in 96-well round-bottom plates. The suppressive capacity of Tregs was measured by the addition of Tregs at Treg : Teff ratios of 0.125:1, 0.25:1, 0.5:1, 1:1. Each sample was tested in triplicates or at least duplicates, the deviation from the mean was in the majority of cases <10 %, deviations up to 15 % were only seen at low Treg : Teff ratios (0.5:1 or 0.125:1). After culture for 72 hours at 37°C and 5% CO 2 in a humified atmosphere, 3 [H]-thymidine (0.037 Mbq/well) was added and cells were cultured for additional 16 hours. 
Statistical analysis
Each result was derived from at least three individual experiments. The mean and standard deviation (SD) is given. The SD is more appropriate than the standard error of the mean (SEM) [25] , which is always smaller than the SD [SEM=SD/(square root of sample size)]. Statistical significance between experimental groups was analyzed using the two-tailed unpaired t-test and p-values <0.05 were considered statistically significant (*p <0.05, **p <0.01, (***p <0.001). (Fig. 1A and B) . This high interindividual variability in healthy volunteers was unexpected and thus we hypothesized that not only the Treg cell population but although the Teff cell population might be heterogeneous. Naïve Teffs could be more susceptible to suppression than already activated Teffs. CD4   +   CD25   high   CD127 -/low Tregs were isolated essentially as in Fig. 1 Differences between experimental groups were analyzed using the two-tailed unpaired t-test (ns = not significant, p-values = *p <0.05, **p <0.01, *** p< 0.001).
Heterogeneity of Teff cells
When CD49d
-Tregs or CD49d + Tregs were tested on CD45RA -Teffs, the suppressive capacity of CD49d -Tregs was higher than the one of CD49d + Tregs (Fig 3B) . 
CD25
-T cells and obtained by MACS. In the present study, we defined two Treg cell populations by elimination of CD127 + T-cells [11, 12] 
-CD45RA -T cell population.
Our findings have implications on previous crossover experiments, comparing Tregs or Teffs from healthy donors and patients with systemic lupus erythematosus [27] , type 1 diabetes [28, 29] , rheumatoid arthritis [30] or multiple sclerosis [31] . The authors provide evidence that Teffs from patients compared to those from healthy donors are less susceptible or even resistant to the suppressive activity of Tregs obtained from patients or healthy donors. Based on our data it seems more likely that these observations are not due to an overall resistance of Teffs from patients but merely reflects heterogeneity of CD4 low as well as CD25 -CD45RA -T cells, display relative resistance to suppression which poses the question to which extent already activated autoreactive T cells will be controlled in vivo after substitution of Tregs.
Abbreviations
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